Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach

<i>Background and Objectives</i>: Periodontal inflammation, often linked to oral microbiota dysbiosis dominated by pathogenic bacteria, remains a significant challenge in periodontitis management. Traditional periodontal therapies primarily reduce the bacterial load but fail to restore t...

Full description

Saved in:
Bibliographic Details
Main Authors: Liliana Sachelarie, Ioana Scrobota, Ioana Romanul, Raluca Iurcov, Georgiana Ioana Potra Cicalau, Liana Todor
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/1/126
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587982698184704
author Liliana Sachelarie
Ioana Scrobota
Ioana Romanul
Raluca Iurcov
Georgiana Ioana Potra Cicalau
Liana Todor
author_facet Liliana Sachelarie
Ioana Scrobota
Ioana Romanul
Raluca Iurcov
Georgiana Ioana Potra Cicalau
Liana Todor
author_sort Liliana Sachelarie
collection DOAJ
description <i>Background and Objectives</i>: Periodontal inflammation, often linked to oral microbiota dysbiosis dominated by pathogenic bacteria, remains a significant challenge in periodontitis management. Traditional periodontal therapies primarily reduce the bacterial load but fail to restore the microbiota balance. Probiotics offer a promising therapeutic adjunct with their ability to enhance beneficial bacteria. This study investigates the effects of probiotics on the oral microbiota, inflammatory markers (IL-1β, TNF-α), and clinical parameters (gingival index, bleeding index, and periodontal pocket depth). <i>Materials and Methods</i>: In this pilot study, 80 patients with moderate-to-severe periodontitis were assigned to two groups. Group A received standard periodontal therapy (non-surgical periodontal therapy (NSPT)) with probiotic supplementation (<i>Lactobacillus reuteri</i>, 2 × 10⁹ CFU daily for 8 weeks), and Group B received standard treatment with a placebo. Microbiological changes were assessed via quantitative PCR, while inflammatory markers (IL-1β, TNF-α) were analyzed using ELISA. Clinical parameters, including the gingival index (GI), bleeding index (BI), and periodontal pocket depth (PPD), were measured at baseline (T0), 4 weeks (T1), and 8 weeks (T2) using standardized methods. <i>Results</i>: Probiotic therapy (Group A) significantly reduced the pathogenic bacteria and increased the beneficial bacteria levels compared to the placebo (<i>p</i> < 0.01). Inflammatory markers decreased by 37% (IL-1β) and 42% (TNF-α), while clinical parameters improved, with reductions in the gingival and bleeding indices (−1.5, −1.3) and a 2 mm decrease in the periodontal pocket depth (<i>p</i> < 0.01). <i>Conclusions</i>: Probiotics, as an adjunct to periodontal therapy, effectively restore the microbiota balance, reduce inflammation, and improve clinical outcomes in periodontitis.
format Article
id doaj-art-325429e4b2db44ada2f7ad767bb256b1
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-325429e4b2db44ada2f7ad767bb256b12025-01-24T13:40:44ZengMDPI AGMedicina1010-660X1648-91442025-01-0161112610.3390/medicina61010126Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative ApproachLiliana Sachelarie0Ioana Scrobota1Ioana Romanul2Raluca Iurcov3Georgiana Ioana Potra Cicalau4Liana Todor5Department of Preclinical Discipline, Faculty of Medicine, Apollonia University, 700511 Iasi, RomaniaDepartment of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, RomaniaDepartment of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, RomaniaDepartment of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, RomaniaDepartment of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, RomaniaDepartment of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, Romania<i>Background and Objectives</i>: Periodontal inflammation, often linked to oral microbiota dysbiosis dominated by pathogenic bacteria, remains a significant challenge in periodontitis management. Traditional periodontal therapies primarily reduce the bacterial load but fail to restore the microbiota balance. Probiotics offer a promising therapeutic adjunct with their ability to enhance beneficial bacteria. This study investigates the effects of probiotics on the oral microbiota, inflammatory markers (IL-1β, TNF-α), and clinical parameters (gingival index, bleeding index, and periodontal pocket depth). <i>Materials and Methods</i>: In this pilot study, 80 patients with moderate-to-severe periodontitis were assigned to two groups. Group A received standard periodontal therapy (non-surgical periodontal therapy (NSPT)) with probiotic supplementation (<i>Lactobacillus reuteri</i>, 2 × 10⁹ CFU daily for 8 weeks), and Group B received standard treatment with a placebo. Microbiological changes were assessed via quantitative PCR, while inflammatory markers (IL-1β, TNF-α) were analyzed using ELISA. Clinical parameters, including the gingival index (GI), bleeding index (BI), and periodontal pocket depth (PPD), were measured at baseline (T0), 4 weeks (T1), and 8 weeks (T2) using standardized methods. <i>Results</i>: Probiotic therapy (Group A) significantly reduced the pathogenic bacteria and increased the beneficial bacteria levels compared to the placebo (<i>p</i> < 0.01). Inflammatory markers decreased by 37% (IL-1β) and 42% (TNF-α), while clinical parameters improved, with reductions in the gingival and bleeding indices (−1.5, −1.3) and a 2 mm decrease in the periodontal pocket depth (<i>p</i> < 0.01). <i>Conclusions</i>: Probiotics, as an adjunct to periodontal therapy, effectively restore the microbiota balance, reduce inflammation, and improve clinical outcomes in periodontitis.https://www.mdpi.com/1648-9144/61/1/126probioticsperiodontal therapyoral microbiota
spellingShingle Liliana Sachelarie
Ioana Scrobota
Ioana Romanul
Raluca Iurcov
Georgiana Ioana Potra Cicalau
Liana Todor
Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
Medicina
probiotics
periodontal therapy
oral microbiota
title Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
title_full Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
title_fullStr Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
title_full_unstemmed Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
title_short Probiotic Therapy as an Adjuvant in the Treatment of Periodontal Disease: An Innovative Approach
title_sort probiotic therapy as an adjuvant in the treatment of periodontal disease an innovative approach
topic probiotics
periodontal therapy
oral microbiota
url https://www.mdpi.com/1648-9144/61/1/126
work_keys_str_mv AT lilianasachelarie probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach
AT ioanascrobota probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach
AT ioanaromanul probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach
AT ralucaiurcov probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach
AT georgianaioanapotracicalau probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach
AT lianatodor probiotictherapyasanadjuvantinthetreatmentofperiodontaldiseaseaninnovativeapproach